Free Trial

Rep. Gilbert Ray Cisneros, Jr. Buys Molina Healthcare, Inc. (NYSE:MOH) Shares

Molina Healthcare logo with Medical background

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Molina Healthcare, Inc. (NYSE:MOH). In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Molina Healthcare stock on April 29th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Beiersdorf Aktiengesellschaft OTCMKTS: BDRFF on 5/2/2025.
  • Purchased $1,001 - $15,000 in shares of Alkami Technology NASDAQ: ALKT on 4/30/2025.
  • Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of DXC Technology NYSE: DXC on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of DOW NYSE: DOW on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Zions Bancorporation, National Association NASDAQ: ZION on 4/29/2025.
  • Purchased $1,001 - $15,000 in shares of O'Reilly Automotive NASDAQ: ORLY on 4/29/2025.
  • Purchased $1,001 - $15,000 in shares of McKesson NYSE: MCK on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 4/29/2025.
  • Sold $1,001 - $15,000 in shares of Humana NYSE: HUM on 4/29/2025.

Molina Healthcare Price Performance

Shares of MOH stock traded down $2.02 on Friday, reaching $323.84. The company's stock had a trading volume of 602,871 shares, compared to its average volume of 681,091. The stock's fifty day simple moving average is $324.73 and its 200-day simple moving average is $308.48. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $365.23. The company has a market capitalization of $17.55 billion, a price-to-earnings ratio of 15.85, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business's revenue was up 12.2% on a year-over-year basis. During the same period last year, the company posted $5.73 EPS. Analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the sale, the director now directly owns 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Molina Healthcare

A number of institutional investors have recently modified their holdings of MOH. Wilmington Savings Fund Society FSB purchased a new stake in shares of Molina Healthcare in the 3rd quarter worth $113,000. Principal Financial Group Inc. lifted its stake in Molina Healthcare by 3.3% in the third quarter. Principal Financial Group Inc. now owns 74,160 shares of the company's stock worth $25,553,000 after acquiring an additional 2,389 shares during the period. Versant Capital Management Inc lifted its stake in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after acquiring an additional 74 shares during the period. GAMMA Investing LLC grew its holdings in Molina Healthcare by 64.5% during the 4th quarter. GAMMA Investing LLC now owns 893 shares of the company's stock worth $260,000 after acquiring an additional 350 shares in the last quarter. Finally, Nordea Investment Management AB increased its position in Molina Healthcare by 7.2% during the 4th quarter. Nordea Investment Management AB now owns 4,445 shares of the company's stock valued at $1,300,000 after purchasing an additional 300 shares during the period. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Robert W. Baird restated a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Sanford C. Bernstein started coverage on shares of Molina Healthcare in a research note on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective for the company. Truist Financial boosted their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Finally, Barclays raised their target price on shares of Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a report on Friday, April 25th. Nine equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $365.38.

Check Out Our Latest Stock Report on MOH

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines